The NextTech: Translational Development of Next-Generation Diagnostic and Therapeutic Devices (R18 Clinical Trial Not Allowed) from the National Institutes of Health (NIH) supports the development and translation of next-generation devices to prevent, monitor, diagnose, and treat disorders within the missions of the NIH BRAIN and HEAL Initiatives, advancing technologies through design-driven development and preclinical testing up to readiness for first-in-human clinical studies.
Applications are open to organizations based in the USA and worldwide. Applications must focus on technology development rather than hypothesis-driven or mechanistic research, and clinical trials are not allowed.
The funding provides up to 750,000 USD in direct costs per year, and applicants may request up to 3 years of support.
Opportunity number: RFA-EB-28-004
Applications open on January 1, 2027. Submission cycles close on February 1, 2027, September 17, 2027, May 26, 2028, February 1, 2029, September 19, 2029, and February 1, 2030.